6 free, board-style GSRH End of Rotation questions — each with the correct answer and a complete explanation. No email, no account required.
Mapped to the clinician-reviewed FirstPassPA bank and the 2026 PAEA Gynecologic, Sexual, and Reproductive Health (GSRH, formerly Women's Health) blueprint. Attempt each one before you reveal the answer.
Question 1Infectious DiseaseEasy
A 22-year-old woman is 8 weeks pregnant at her first prenatal visit. She has no medical history. Which of the following is recommended during this pregnancy?
ALive attenuated intranasal influenza vaccine
BMeasles, mumps, and rubella virus vaccine (MMR)
CTetanus, diphtheria, and acellular pertussis (Tdap)
DVaricella (chickenpox) live-attenuated vaccine
EHuman papillomavirus 9-valent vaccine (9vHPV)
Reveal answer & full explanation
Correct answer: C — Tetanus, diphtheria, and acellular pertussis (Tdap)
ALive attenuated intranasal influenza vaccine
BMeasles, mumps, and rubella virus vaccine (MMR)
CTetanus, diphtheria, and acellular pertussis (Tdap)✓
DVaricella (chickenpox) live-attenuated vaccine
EHuman papillomavirus 9-valent vaccine (9vHPV)
Why Tetanus, diphtheria, and acellular pertussis (Tdap) is correct
Tdap is recommended during every pregnancy, given at 27–36 weeks
Timing maximizes maternal immunoglobulin G (IgG) antibody transfer to the newborn, protecting them from pertussis before their first diphtheria, tetanus, and acellular pertussis (DTaP) vaccine at 2 months
Why the others are wrong
Live attenuated influenza vaccine — the inactivated influenza vaccine (not live attenuated influenza vaccine (LAIV)) is safe in all trimesters; LAIV is contraindicated in pregnancy
Measles, mumps, and rubella (MMR) — live vaccine; contraindicated in pregnancy
Varicella — live vaccine; contraindicated in pregnancy
Human papillomavirus 9-valent vaccine (9vHPV) — tempting because it is not a live vaccine and she is within the catch-up age range, but HPV vaccination is not recommended during pregnancy and is deferred until after delivery; an inadvertent dose given in pregnancy needs no intervention
Question 2ReproductiveMedium
A 30-year-old woman seeks evaluation after 14 months of regular unprotected intercourse without conception. She has no history of pelvic surgery or infection. The clinician is assessing whether ovulatory dysfunction contributes. Which menstrual history finding most strongly supports that possibility?
AUnpredictable periods separated by two or three months
BBrief pelvic pain halfway between regular periods
CPredictable periods recurring about every four weeks
DIrregular spotting between otherwise predictable periods
EMenstrual cramps beginning shortly before each period
Reveal answer & full explanation
Correct answer: A — Unpredictable periods separated by two or three months
AUnpredictable periods separated by two or three months✓
BBrief pelvic pain halfway between regular periods
CPredictable periods recurring about every four weeks
DIrregular spotting between otherwise predictable periods
EMenstrual cramps beginning shortly before each period
Why Unpredictable periods separated by two or three months is correct
Markedly infrequent irregular menses suggest infrequent or absent ovulation.
Disrupted follicular development reduces predictable release of an oocyte.
American Society for Reproductive Medicine 2021 fertility-evaluation guidance recognizes oligomenorrhea or amenorrhea as sufficient clinical evidence to investigate anovulation.
Why the others are wrong
Predictable periods recurring about every four weeks - Regular cycles in this range usually support ovulation, although exceptions exist.
Irregular spotting between otherwise predictable periods - Intermenstrual spotting with predictable cycles points toward a structural or cervical source, such as an endometrial polyp, or brief midcycle spotting at ovulation; the predictable cycles still support regular ovulation.
Menstrual cramps beginning shortly before each period - Primary menstrual cramps do not establish ovulatory dysfunction.
Brief pelvic pain halfway between regular periods - Brief midcycle discomfort can accompany ovulation and does not establish anovulation.
Additional high-yield points
Investigate underlying causes such as polycystic ovary syndrome, thyroid disease, or hypothalamic dysfunction.
When applicable, evaluate both partners rather than assuming the cause is exclusively female.
Question 3EndocrineMedium
A 30-year-old woman has 3 months of secondary amenorrhea and galactorrhea. She is not pregnant. Serum prolactin is 420 ng/mL and TSH is normal. MRI shows a 12 mm sellar mass. Which of the following is the most appropriate treatment?
ABromocriptine
BRadiation therapy
CCabergoline
DTranssphenoidal surgery
EOral contraceptives
Reveal answer & full explanation
Correct answer: C — Cabergoline
ABromocriptine
BRadiation therapy
CCabergoline✓
DTranssphenoidal surgery
EOral contraceptives
Why Cabergoline is correct
This is a macroprolactinoma (10 mm or larger) presenting with amenorrhea-galactorrhea; a prolactin above 250 ng/mL with a macroadenoma indicates a prolactin-secreting tumor rather than stalk effect from a nonfunctioning mass, which rarely raises prolactin above about 150 ng/mL
Medical treatment with a dopamine agonist (DA) is first-line
Cabergoline is preferred over bromocriptine: twice-weekly dosing, better tolerated, and higher efficacy — normalizes prolactin in most patients (over 90% with microadenomas and about 77% with macroadenomas in a large series) and shrinks most macroadenomas
Why the others are wrong
Bromocriptine — a dopamine agonist but less preferred than cabergoline: less effective at normalizing prolactin and shrinking the tumor, dosed one to three times daily, and less well tolerated
Transsphenoidal surgery — used for dopamine-agonist resistance or intolerance, pituitary apoplexy, or vision loss not responding to DA therapy; not standard first-line therapy, because a dopamine agonist is the usual initial treatment even for macroadenomas
Radiation therapy — reserved for refractory cases; not first-line management
Oral contraceptives — estrogen-progestin therapy can treat hypogonadism in a microprolactinoma when fertility is not desired, but it neither lowers prolactin nor shrinks the tumor, so a 12 mm macroadenoma needs a dopamine agonist to control tumor growth
Question 4PsychiatryMedium
A 34-year-old woman is 6 weeks postpartum after an uncomplicated vaginal delivery. She is breastfeeding exclusively. She has persistent sadness, crying spells, difficulty bonding with her infant, hopelessness, and poor sleep beyond infant care for the past 3 weeks. She denies suicidal ideation (SI). Patient Health Questionnaire-9 (PHQ-9) score is 16. Which of the following is the most appropriate management?
ADiscontinue breastfeeding and initiate fluoxetine
BTransdermal estradiol plus psychotherapy referral
CReassurance and watchful waiting
DWeekly home visits and lactation support
ESertraline plus psychotherapy referral
Reveal answer & full explanation
Correct answer: E — Sertraline plus psychotherapy referral
ADiscontinue breastfeeding and initiate fluoxetine
BTransdermal estradiol plus psychotherapy referral
CReassurance and watchful waiting
DWeekly home visits and lactation support
ESertraline plus psychotherapy referral✓
Why Sertraline plus psychotherapy referral is correct
This patient has postpartum depression (PPD): PHQ-9 score of 16, 3 weeks of symptoms, and difficulty bonding with her infant.
First-line treatment is a selective serotonin reuptake inhibitor (SSRI) plus psychotherapy (cognitive behavioral therapy (CBT)).
Sertraline is first-line in breastfeeding women: extensive safety data, low milk transfer.
Other breastfeeding-safe SSRIs include escitalopram and paroxetine.
Why the others are wrong
Discontinue breastfeeding and initiate fluoxetine — Discontinuing breastfeeding is not required; sertraline is safe during breastfeeding.
Weekly home visits and lactation support — Supportive contact and lactation help do not treat moderately severe PPD; a PHQ-9 of 16 with impaired bonding requires an antidepressant plus psychotherapy, not monitoring alone.
Reassurance and watchful waiting — Appropriate for postpartum blues (days 1–14, mild, self-limited); this patient's PHQ-9 of 16 and 3 weeks of impairing symptoms meet criteria for PPD and require treatment.
Transdermal estradiol plus psychotherapy referral — tempting because the abrupt postpartum fall in estrogen is implicated in PPD and estradiol has been studied as a treatment, but it is not a recommended therapy; estrogen may reduce milk supply in this exclusively breastfeeding mother, and an SSRI such as sertraline remains first-line pharmacotherapy alongside psychotherapy.
Additional high-yield points
Postpartum blues: onset days 1–14, mild, self-limited.
Postpartum depression (PPD): onset within the first year postpartum, PHQ-9 ≥10, persistent and impairs functioning.
Question 5CardiovascularEasy
A 32-year-old woman with no prior cardiac history presents to the ED with chest pain and shortness of breath 3 weeks after delivering her first baby. She had an uncomplicated vaginal delivery. Echo shows left ventricular (LV) dilation with ejection fraction (EF) of 30% and no regional wall motion abnormalities. B-type natriuretic peptide (BNP) is 1,840 pg/mL. She is not breastfeeding. Which of the following is the most likely diagnosis?
ATakotsubo cardiomyopathy
BAcute myocarditis
CPeripartum cardiomyopathy
DMyocardial infarction
EPulmonary embolism
Reveal answer & full explanation
Correct answer: C — Peripartum cardiomyopathy
ATakotsubo cardiomyopathy
BAcute myocarditis
CPeripartum cardiomyopathy✓
DMyocardial infarction
EPulmonary embolism
Why Peripartum cardiomyopathy is correct
Peripartum cardiomyopathy (PPCM) is defined as new-onset heart failure with reduced ejection fraction (HFrEF) occurring toward the end of pregnancy or in the months after delivery (classically defined as the last month of pregnancy through 5 months postpartum) without another identifiable cause
Ejection fraction (EF) must be <45% for the diagnosis; this patient's EF is 30%
Pathophysiology: prolactin is cleaved into an anti-angiogenic, pro-apoptotic 16-kDa fragment (vasoinhibin) that injures the cardiac microvasculature and impairs cardiomyocyte function
Why the others are wrong
Pulmonary embolism - Pulmonary embolism would not cause LV dilation or reduced EF on echocardiogram; echo findings here are diagnostic of a cardiomyopathy
Acute myocarditis - Myocarditis can mimic PPCM and must be excluded, but it usually follows a viral prodrome and can occur at any time; with no viral illness reported and new systolic heart failure arising in the defining postpartum window, PPCM is the most likely diagnosis
Takotsubo cardiomyopathy - Takotsubo produces regional apical ballooning with basal hyperkinesis after an acute stressor, whereas this echo shows global LV dilation with no regional wall motion abnormalities in the defining postpartum window
Myocardial infarction - postpartum chest pain and dyspnea raise concern for acute coronary syndrome, and pregnancy-associated MI (often from spontaneous coronary artery dissection) occurs most often in the first postpartum weeks, but an infarct large enough to drop the EF to 30% produces regional wall motion abnormalities in a coronary territory, whereas this echo shows global LV dilation with no regional wall motion abnormalities
Additional high-yield points
Treatment includes standard HFrEF guideline-directed medical therapy: an ACE inhibitor after delivery (enalapril or captopril if breastfeeding) or an ARB if she is neither pregnant nor breastfeeding, beta-blocker (carvedilol or metoprolol), and diuretics (furosemide)
Bromocriptine (a prolactin inhibitor) may be considered for women NOT breastfeeding, always with anticoagulation because it is prothrombotic (off-label and still considered investigational in the US; supported by European trial data and ESC guidance)
Anticoagulation is often recommended, especially when EF is severely reduced, because of the high thromboembolic risk in PPCM
Many women recover ejection fraction; close follow-up is essential
Question 6GastrointestinalEasy
A 32-year-old woman presents with 5 days of right lower quadrant pain, low-grade fever, and nausea. She is 18 weeks pregnant. WBC is 13,800. Graded compression ultrasound shows a noncompressible 10 mm appendix with periappendiceal fat stranding and no free air or abscess. She has rebound tenderness in the RLQ. Which of the following is the most appropriate management?
ALaparoscopic appendectomy
BBroad-spectrum antibiotics with close clinical monitoring
CObservation with serial imaging
DMRI of the abdomen and pelvis before any intervention
ECT of the abdomen and pelvis with IV contrast
Reveal answer & full explanation
Correct answer: A — Laparoscopic appendectomy
ALaparoscopic appendectomy✓
BBroad-spectrum antibiotics with close clinical monitoring
CObservation with serial imaging
DMRI of the abdomen and pelvis before any intervention
ECT of the abdomen and pelvis with IV contrast
Why Laparoscopic appendectomy is correct
Appendicitis in pregnancy at 18 weeks (second trimester): appendectomy is the definitive treatment, and current SAGES guidance (2024) favors a laparoscopic approach while the uterine fundus is below the umbilicus (about 20 weeks)
At 18 weeks, laparoscopy is feasible because the uterine fundus is still below the umbilicus and does not yet limit port placement or working space
Fetal loss is about 2% with uncomplicated appendicitis and rises several-fold with perforation, so surgery should not be delayed
The gravid uterus may push the appendix upward later in pregnancy (studies disagree), and a mild leukocytosis is normal in pregnancy; both can delay diagnosis and increase perforation risk
Why the others are wrong
Broad-spectrum antibiotics with close clinical monitoring — antibiotics alone have not been shown to be effective in pregnancy, and current guidelines (SAGES 2024) favor appendectomy; a failed course risks perforation and fetal loss
Observation with serial imaging — delays definitive treatment in a patient with confirmed appendicitis and peritoneal findings, unacceptably raising perforation risk
MRI of the abdomen and pelvis before any intervention — non-contrast MRI is reserved for the pregnant patient whose ultrasound is nondiagnostic; here ultrasound already shows a noncompressible 10 mm appendix with fat stranding, so more imaging only delays appendectomy and raises perforation risk
CT of the abdomen and pelvis with IV contrast — tempting because CT is the most accurate test for appendicitis in nonpregnant adults, but ultrasound has already confirmed the diagnosis, so a CT scan only delays appendectomy and adds fetal radiation exposure; in pregnancy, MRI rather than CT is the preferred second-line study when ultrasound is nondiagnostic
Additional high-yield points
Obtain obstetric consultation before surgery to plan perioperative fetal and maternal monitoring
That's 6 of 7,700+. Get the rest.
Unlock the full FirstPassPA bank — 7,700+ board-style questions, all seven EOR rotations with a focused GSRH set, flashcards, and an AI tutor that explains every answer. Start your 7-day free trial — no credit card.
Yes. Every question here shows the full vignette, the correct answer, and a complete explanation with no email or account required. A free 7-day trial unlocks the full 7,700+ question bank, all seven EOR rotations, flashcards, and an AI tutor.
Are these questions aligned with the 2026 Gynecologic, Sexual, and Reproductive Health (GSRH, formerly Women's Health) EOR blueprint?
Yes. They are drawn from the clinician-reviewed FirstPassPA bank, mapped to the NCCPA/PAEA blueprint and this rotation's content areas. PAEA's updated End of Rotation exams are effective as of July 27, 2026 (Surgery moved to its rebuilt blueprint earlier); see what changed on the Gynecologic, Sexual, and Reproductive Health (GSRH, formerly Women's Health) exam on our blueprint-changes page.
How should I use these GSRH EOR practice questions?
Attempt each vignette before revealing the answer, then read the full explanation even when you get it right — the reasoning for why the distractors are wrong is where most of the learning is. Then practice focused, blueprint-weighted question blocks in the app as your exam date nears.
Educational use only. These questions are a study aid for PA students and are not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.